Statins should be offered to everyone who has chronic kidney disease, says NICE
Healthcare professionals should offer statins to millions of people with chronic kidney disease (CKD). This will help to manage their increased risk of cardiovascular disease (CVD), says NICE.
Latest news headlines
NICE is seeking views on a new conflicts of interest policy to ensure its committees’ decisions are fair and unbiased.
24 July 2017
Around 2,200 patients a year with multiple myeloma are to benefit from a new, tolerable treatment on the NHS following approval by NICE.
19 July 2017
Following the recent launch by the publishers of the British National Formulary (BNF) and British National Formulary for children (BNFC) of a new, faster, easier to use and access app, NICE has confirmed that its BNF app will be withdrawn later this year.
13 July 2017
People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said cabozantinib should be available on the NHS.
10 July 2017
An agreement has been reached that means more people with a rare life threatening disease can be offered an innovative new drug.
05 July 2017
Paramedics with advanced training can reduce the number of patients admitted to hospital unnecessarily, says NICE.
03 July 2017